XML 73 R96.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity - Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Stock-based compensation      
Stock-based compensation expense, net of $0 tax in 2016, 2017 and 2018 $ 3,880 $ 5,307 $ 8,423
Stock-based compensation expense, tax $ 0 $ 0 $ 0
2016 Plan      
Stock-based compensation      
Number of shares available for future grant 2,054,993    
2016 Plan | Stock options      
Stock-based compensation      
Vesting period 3 years    
Contractual term 10 years    
Number of Shares      
Outstanding at the beginning of the period (in shares) 8,699,677    
Granted (in shares) 2,183,691    
Exercised (in shares) (58,602)    
Forfeited or expired (in shares) (1,703,101)    
Outstanding at the end of the period (in shares) 9,121,665 8,699,677  
Exercisable at the end of the period (in shares) 6,246,982    
Vested and expected to vest at the end of the period (in shares) 9,121,665    
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 8.06    
Granted (in dollars per share) 2.19    
Exercised (in dollars per share) 1.79    
Forfeited or expired (in dollars per share) 10.07    
Outstanding at the end of the period (in dollars per share) 6.32 $ 8.06  
Exercisable at the end of the period (in dollars per share) 8.31    
Vested and expected to vest at the end of the period (in dollars per share) $ 6.32    
Additional option disclosures      
Outstanding at the end of the period, weighted average remaining contractual term 5 years 9 months 26 days    
Exercisable at the end of the period, weighted average remaining contractual term 4 years 6 months 7 days    
Vested and expected to vest at the end of the period, weighted average remaining contractual term 5 years 9 months 26 days    
Outstanding at the end of the period, aggregate intrinsic value $ 1,909    
Exercisable at the end of the period, aggregate intrinsic value 812    
Vested and expected to vest at the end of the period, aggregate intrinsic value 1,909    
Total unrecognized compensation cost related to non-vested shares $ 1,900    
Weighted average period over which the total unrecognized compensation cost related to non-vested shares is expected to be recognized 1 year 5 months 12 days    
Total fair value of shares vested $ 1,600    
Weighted-average assumption used for grants      
Dividend yield 0.00% 0.00% 0.00%
Expected volatility     63.61%
Expected volatility, minimum 57.30% 70.20%  
Expected volatility, maximum 61.50% 74.60%  
Risk-free interest rate     2.05%
Risk-free interest rate, minimum 2.11% 2.70%  
Risk-free interest rate, maximum 2.53% 2.71%  
Expected life 6 years 6 years 6 years
Stock-based compensation      
Weighted-average grant date fair values of options granted (in dollars per share) $ 1.28 $ 0.88 $ 1.67
Exercised during the period, aggregate intrinsic value $ 100 $ 0  
Stock-based compensation expense $ 2,200 $ 2,000 $ 2,200
2016 Plan | Stock options | Vesting over the first year      
Stock-based compensation      
Vesting percentage 34.00%    
2016 Plan | Stock options | Vesting over the second year      
Stock-based compensation      
Vesting percentage 33.00%    
2016 Plan | Stock options | Vesting over the third year      
Stock-based compensation      
Vesting percentage 33.00%    
Asset impairments and other charges      
Stock-based compensation      
Stock-based compensation expense, net of $0 tax in 2016, 2017 and 2018     $ 300